Page 12 - Nasdaq Fold News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Amicus Therapeutics (NASDAQ:FOLD – Get Rating) and Maravai LifeSciences (NASDAQ:MRVI – Get Rating) are both mid-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their dividends, profitability, valuation, institutional ownership, risk, earnings and analyst recommendations. Valuation and Earnings This table compares Amicus Therapeutics and […]

Fieldpoint Private Securities LLC grew its position in shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD – Get Rating) by 44.5% in the 4th quarter, HoldingsChannel.com reports. The fund owned 10,270 shares of the biopharmaceutical company’s stock after purchasing an additional 3,161 shares during the quarter. Fieldpoint Private Securities LLC’s holdings in Amicus Therapeutics were worth $119,000 […]

Amicus Therapeutics, Inc. (NASDAQ:FOLD – Get Rating) COO Bradley L. Campbell sold 10,940 shares of the company’s stock in a transaction on Friday, March 18th. The shares were sold at an average price of $10.00, for a total value of $109,400.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which […]

Analysts expect Amicus Therapeutics, Inc. (NASDAQ:FOLD – Get Rating) to announce sales of $79.69 million for the current quarter, according to Zacks. Three analysts have provided estimates for Amicus Therapeutics’ earnings, with estimates ranging from $76.20 million to $84.82 million. Amicus Therapeutics reported sales of $66.40 million in the same quarter last year, which indicates […]